Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Eribulin mesilate added to chemotherapy in patients with bladder cancer

Feb. 10, 2012

Sanofi synthesizes new fibroblast growth factor receptor antagonists

Feb. 10, 2012

Prometheus Laboratories enters collaboration with leading pharmaceutical company

Feb. 9, 2012

RedHill receives approval from Health Canada to begin RHB-102 trial

Feb. 9, 2012

Detailed results presented of phase III regorafenib study

Feb. 9, 2012

FDA grants priority review for pertuzumab

Feb. 8, 2012

Bio-Path completes treatment of second cohort in BP-100-1.01 study

Feb. 8, 2012

Erivedge launched in U.S.

Feb. 8, 2012

Japanese authorities remove condition for approval of Tarceva in NSCLC

Feb. 8, 2012

New vaccines for human papillomavirus prepared in China

Feb. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...